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Objective: In conditions of continuous high-fat (HF) intake, the degree of saturation of the fatty acids (FAs) in the diet might
have a crucial role in the onset of obesity and its metabolic complications. In particular, the FA composition of the diet might
influence the storage form of lipids inside skeletal muscle. The aim of the present study was to examine whether the FA
composition of HF diets differentially affects weight gain and accumulation of myocellular triacylglycerol (TAG) and
diacylglycerol (DAG). Furthermore, we examined whether the FA composition of the diet was reflected in the composition of the
myocellular lipid intermediates.
Design: C57Bl6 mice were fed HF diets (45% energy) mainly containing palm oil (PO), cocoa butter (CB), olive oil (OO) or
safflower oil (SO; n¼6 per group) for 8 weeks. A low-fat diet (10% energy, PO) was used as control. Body weight was monitored
weekly. At the end of the dietary intervention, myocellular TAG and DAG content and profiles were measured.
Results: We here show that HF_CB prevented weight gain after 8 weeks of HF feeding. Furthermore, the HF diet rich in SO
prevented the accumulation of both myocellular TAG and DAG. Interestingly, the FA composition of DAG and TAG in skeletal
muscle was a reflection of the dietary FA composition.
Conclusion: Already after a relatively short period, the dietary FA intake relates to the FA composition of the lipid metabolites in
the muscle. A diet rich in polyunsaturated FAs seems to prevent myocellular lipid accumulation.
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Introduction
Obesity is a serious health problem, predisposing individuals
to a range of metabolic complications. Skeletal muscle and
adipose tissue are important organs in regulating fatty acid
(FA) metabolism, and disturbances in their function may
lead to insulin resistance and dyslipidemia.
1 When the
capacity of adipose tissue to store lipid becomes insufficient,
which is most often associated with chronic excessive energy
intake (in particular by means of dietary fat), this may lead to
an increased supply of triacylglycerols (TAGs) and free FAs to
non-adipose tissues, such as skeletal muscle and liver.
1
Consequently, if the uptake of FAs exceeds the capacity or
the need to oxidize fat in skeletal muscle or liver, the FAs
are stored. Indeed, TAG content in human skeletal muscle
has been reported to increase by 36–90% after high-fat
(HF) feeding periods ranging from 24h to 7 weeks,
2–5
and numerous studies have shown a negative association
between fat accumulation in these tissues and insulin
sensitivity.
6–9
Next to total fat content, it has nowadays become
apparent that dietary fat quality (that is, dietary FA
composition) may also be important, as each individual FA
has distinct chemical properties linked to its unique
structure. Thus, it has been shown that the type of dietary
fat can influence the onset of obesity by differentially Received 17 November 2010; revised 4 April 2011; accepted 23 May 2011
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have been shown to result in higher rates of weight gain,
10,11
whereas polyunsaturated FAs (PUFAs) did not induce obesity
in mice and rats.
12,13 In humans, Doucet et al.
14 showed that
waist circumference, as a measure of central adiposity, is
increased in individuals with a higher total, saturated and
monounsaturated fat content in their diets compared with
PUFAs.
Furthermore, the degree of saturation of the diet has been
suggested to affect the rate of storage of FA intermediates.
Both in rats and humans, it was shown that unsaturated FAs
are oxidized more rapidly than SFAs,
15,16 and SFAs, which are
less readily oxidized, accumulate as diacylglycerols (DAGs)
and ceramide in vitro,
17 whereas monounsaturated FAs
(MUFAs) and PUFAs are efficiently stored as TAGs.
17–19
Despite these suggestions that dietary fat quality can affect
body weight gain and muscle fat storage, no studies are
available that consistently tested the effect of well-controlled
experimental HF diets varying in FA composition on
myocellular lipid content. Moreover, whereas it has been
shown for adipose tissue that TAG composition reflects
habitual dietary FA intake over a considerably long time,
20,21
such information is lacking for skeletal muscle.
Therefore, we investigated whether the FA composition of
HF diets, with different degree of saturation, differentially
affects body weight gain and storage of dietary FAs into
either myocellular TAG or DAG. Furthermore, we were
interested whether, after a short period of change in dietary
fat intake, the FA profiles of myocellular TAG and DAG
represent the dietary FA composition.
Materials and methods
Animals and diets
Thirty, male C57Bl/6J mice, aged 4 weeks, were obtained
from Harlan Laboratories (Horst, The Netherlands) and were
acclimatized, two per cage, to the environmentally con-
trolled laboratory environment (temperature 22±1 1C and
relative humidity 55±2%) with a 12:12 light-dark cycle.
Three weeks before the onset of the experimental interven-
tion, mice were allowed ad libitum access to a low-fat diet
(LF_PO, palm oil; 70%, 10% and 20% of calories as
carbohydrate, fat and protein, respectively) that contained
both SAT FAs and MUFAs derived from PO (Research Diet
Services, Wijk bij Duurstede, The Netherlands).
After these 3 weeks, mice were randomly assigned to one
of the six experimental diet groups for a period of 8 weeks.
The first group was maintained on the LF_PO (n¼6). The
other mice switched to a HF diet (35% carbohydrate; 45%
fat; and 20% protein) that consisted mainly of SFAs, derived
from cocoa butter (HF_CB, n¼6), a mixture of both SFAs and
MUFAs, derived from PO (HF_PO, n¼6), two mixtures
primarily of MUFAs and PUFAs, derived from olive oil
(HF_OO, n¼6) and safflower oil (HF_SO, n¼6) (Research
Diet Services). The exact composition of the diets is given in
Table 1. Animals were provided with food and water
ad libitum throughout the experimental period. Body weight
of the mice was monitored weekly during the dietary
intervention period. To determine food intake, non-absorb-
able chromic oxide was supplemented to the diets for 1 week
(week 5 of the diet intervention). At the end of this week,
feces were quantitatively collected during 48h and fecal
chromic oxide levels were determined as previously de-
scribed.
22 These fecal chromic oxide levels were then used to
calculate the energy intake per mouse per day.
All experiments were approved by the Institutional Animal
Care and Use committee of the Wageningen University and
complied with the principles of laboratory animal care.
Oral glucose tolerance test
To investigate the effect of dietary FA composition on whole-
body glucose tolerance, mice underwent an oral glucose
tolerance test after 7 weeks of the dietary intervention. After
a 6-hour fast, glucose (20% wt/vol solution) was adminis-
tered by oral gavage at a dose of 2.5g/kg body weight, and
glucose was measured in blood obtained from the tail vein,
before glucose administration (t¼0) and at 15, 30, 45, 60
and 90min thereafter using Accu-Chek blood glucose meters
(Roche Diagnostics, Almere, The Netherlands). Incremental
area under the curve of glucose concentration versus time
curve was calculated using the trapezoidal method.
Tissue sampling
After 8 weeks of dietary intervention, mice were anaesthe-
tized in the postprandial phase at 1400 hours with a mixture
of isoflurane, nitrogen oxide and oxygen, followed by
cervical dislocation. Gastrocnemius muscle was rapidly
dissected out, immediately frozen in liquid nitrogen-cooled
isopentane and stored at  801C until further analyses.
Epididymal fat depots were isolated and weighed.
Table 1 Macronutrient composition of the diets
LF_PO HF_PO HF_CB HF_OO HF_SO
D12450B D12451 D12451 D12451 D12451
Based on formula
Protein (kcal%) 20 20 20 20 20
Carbohydrate (kcal%) 70 35 35 35 35
Fat (kcal%) 10 45 45 45 45
Total 100 100 100 100 100
Percentage of fatty acids
C16:0 43 43 25 12 6
C18:0 4 4 34 2 3
C18:1 41 41 33 73 12
C18:2 10 10 3 10 78
Abbreviations: HF_CB, high-fat cocoa butter; HF_OO, high-fat olive oil;
HF_PO, high-fat palm oil; HF_SO, high-fat safflower oil; LF_PO, low-fat palm oil.
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Total lipids were extracted from frozen muscle using the
method of Folch et al.
23 The extracts were filtered and lipids
recovered in the chloroform phase. Total TAGs and DAGs
were isolated using thin-layer chromatography on Silica Gel
60 A plates (Merck kGaA, Darmstadt, Germany) developed in
petroleumbenzin-diethyl ether-acetic acid (120:25:1.5 by
volume) and visualized by rhodamine 6G. The TAG and
DAG bands were scraped from the plate and methylated
using a mixture of toluene–methanol (BF3/methanol 14%;
20–55–25% by volume), as described by Morrison and
Smith.
24 The methylated FAs were extracted with hexane
and analyzed by capillary gas liquid chromatography using a
50m 0.25mm CP-sil 88 silica column (Varian, Agilent,
Santa Clara, CA, USA), with helium as carrier gas at a flow of
130kPa. The column oven was maintained at 1651C for
10min and increased at a rate of 51Cmin
 1 to 1901C. This
temperature was maintained for 15min. Then temperature
was increased to 2301C for 22min, with a flow rate of
21Cmin
 1. FA methyl esters were identified by comparing
retention times to those of known standards. Inclusion of an
internal standard, 17:0 (heptadecanoic acid, internal stan-
dard for TAG), 19:0 (dinonadecanoic acid, internal standard
for DAG) and an average molecular mass for each FA methyl
ester permits quantification of the amount of TAG and DAG
in the sample, expressed as micromolar per gram of wet
tissue weight. Contribution of the individual FAs as percen-
tage of total DAG and TAG content was calculated.
Enzyme activity measurements
Muscle b-hydroxyacyl-CoA dehydrogenase and citrate
synthase, and enzyme activities were determined spectro-
photometrically. In short, 30 (20mm) sections of muscle were
added to 100ml sucrose-EDTA-Tris buffer (250mmoll
 1
sucrose, 2mmoll
 1 EDTA and 10mmoll
 1 Tris (pH 7.4))
and sonicated (Branson 2210; Branson Ultrasonics, Danbury,
CT, USA) for 25s. Samples were centrifuged (10min, 10000g,
41C), and the supernatants were analyzed spectrophotome-
trically (Multiskan Spectrum; Thermo labsystems, Breda,
The Netherlands) to determine b-hydroxyacyl-CoA dehydro-
genase
25 and citrate synthase enzyme activities.
26 Activity of
proteins is expressed as Ug
 1 protein.
Measurement of liver fat content
Animals were killed and livers were rapidly excised, rinsed of
blood and homogenized by polytron (Brinkman Instruments,
Westbury, NY, USA) in homogenization buffer (containing
10mM Tris, 2 mM EDTA and 0.25M sucrose, pH 7.5, 41C).
Triglyceride concentration was determined by the commer-
cially available enzymatic kit (Instruchemie, Delfzijl, The
Netherlands). Briefly, homogenates were centrifuges at
12000g for 10min, and TAG amounts in the supernatants
were determined by enzyme-linked immunosorbent assay.
The TAG content was corrected for tissue weight.
Western blotting
Muscle samples were homogenized as described previously
27
and processed for standard SDS-polyacrylamide gel electro-
phoresis and western blotting. Protein concentration was
assessed, and equal amounts of protein were loaded per lane.
Actin was used as a loading control. Membranes were
incubated with antibodies against oxidative phosphoryla-
tion proteins (OXPHOS) (MS601; MitoSciences, Eugene, OR,
USA), peroxisome proliferator-activated receptor-gamma
coactivator 1 alpha (PGC1a) (516557; Calbiochem; VWR
International BV, Amsterdam, The Netherlands) and adipose
tissue triglyceride lipase (ATGL) (2138; Cell Signaling
Technology; Bioke ´; Leiden, The Netherlands). Blots incu-
bated with OXPHOS and PGC1a were probed with IR-
Dye800-conjugated or IRDye700-conjugated secondary
antibodies (Rockland, Gilbertsville, PA, USA, and LICOR
Biosciences, Westburg, Leusden, The Netherlands), and
bands at a molecular weight corresponding to the control
samples were quantified using the Odyssey infrared imaging
system (LICOR Biosciences, Wateringen, The Netherlands).
Blots detecting ATGL were probed with the appropriate horse
radish-conjugated antibodies, and after incubation, specific
protein bands were visualized by chemiluminescence and
analyzed by Chemidoc XRS system (Bio-Rad, Veenendaal,
The Netherlands).
Statistical analysis
Results are presented as the mean±s.e. Differences between
groups were analyzed by one-way analysis of variance, with
least significant differences post hoc correction. The accepted
level of statistical significance was Po0.05 for all analyses.
All calculations were done using the Statistical Package for
Social Sciences (SPSS 16.0 software, SPSS, Chicago, IL, USA).
Results
Body weight, food intake, feces production and epididymal fat
pads
Body weights gradually increased over the 8 weeks of
intervention in all dietary groups (Figure 1). However, mice
receiving HF_PO gained the most weight, whereas LF_PO
and HF_CB mice displayed the lowest weight gain over the
entire feeding protocol. The delta body weight was signifi-
cantly different between groups (þ43% in HF_PO versus
LF_PO, P¼0.001; þ41% in HF_PO versus HF_CB, P¼0.001;
þ20% in HF_PO versus HF_OO, P40.05; and þ26% in
HF_PO versus HF_SO, P¼0.030). Food intake between the
different dietary groups was not different (LF_PO, 12.4±1.4;
HF_PO, 12.1±1.4; HF_CB, 10.0±0.4; HF_OO, 12.9±1.1; and
HF_SO, 15.1±0.7kcal per day, P40.05). Feces production
was significantly higher for HF_CB compared with the other
dietary groups (LF_PO, 0.40±0.02; HF_PO, 0.41±0.03;
HF_CB, 0.53±0.01; HF_OO, 0.39±0.01; and HF_SO,
0.42±0.02g per day, Po0.05). Epididymal fat pad weights
were not different between the dietary groups (LF_PO,
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Nutrition and Diabetes1.31±0.15; HF_PO, 2.14±0.13; HF_CB, 1.74±0.15; HF_OO,
1.72±0.28; and HF_SO, 1.71±0.25g, P40.05).
Muscle lipid content
After 8 weeks of dietary intervention, skeletal muscle TAG
and DAG content were assessed.
Skeletal muscle TAG content increased to the same extent
in all HF diets compared with LF_PO (Po0.05, Figure 2a),
except for HF_SO, which did not lead to accumulation of
myocellular TAG.
HF_PO, HF_CB and HF_OO also significantly increased
myocellular DAG levels compared with LF_PO (Po0.05),
whereas HF_SO did not significantly increase DAG content
(P¼0.39, Figure 2b).
Dietary FA composition exerted a profound effect on
the FA profile in skeletal muscle DAG and TAG (Figures 3a
and b). Both LF_PO and HF_PO, which contain an almost
equal amount of SFAs (49% of total FAs, Table 1) and MUFAs
(41% of total FAs), increased the proportion of the SFA C16:0
and the MUFA C18:1 in both DAG and TAG. Also, HF_OO
and HF_SO, two diets that are characterized by a high
amount of MUFAs (73% of total FAs) and PUFAs (78% of total
FAs), respectively, elevated the proportion of the unsaturated
FAs in both skeletal muscle DAG and TAG content. For
HF_OO, the increased proportion of MUFAs resulted in an
increase in C18:1, whereas for HF_SO the elevated PUFAs in
DAG and TAG content were due to an increase in C18:2.
HF_CB, a diet consisting of 63% of SFAs and of 37% of
unsaturated FAs, elevated both the proportion of C18:0 and
C18:1 in skeletal muscle DAG and TAG content.
Glucose tolerance
Fasting blood glucose values were not affected by the FA
composition of the different diets (LF_PO, 10.18±0.40;
Figure 2 Effect of dietary FA composition on TAG (a) and DAG (b) content in gastrocnemius muscle. Data are expressed as mean±s.e.m. (n¼6). *Po0.05 LF_PO
versus HF_PO, HF_CB and HF_OO.
Figure 1 Effect of dietary FA composition on body weight gain. Body weight
gradually increased over the 8 weeks of dietary intervention. Data are
expressed as mean±s.e.m. (n¼6). *Po0.05 HF_PO versus LF_PO and HF_CB.
Figure 3 Effect of dietary FA composition on skeletal muscle DAG (a) and
TAG (b) FAs. Representation of the FAs that account for the highest
percentage in the diet and account, on average, for 80% of total DAG and
TAG content. Data are expressed as mean±s.e.m. (n¼6).
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11.5±1.59; and HF_SO, 10.88±0.65mM, P40.05).
The degree of saturation of the different HF diets had no
major influence on whole-body glucose tolerance, that is, all
the HF diets reduced the clearance of glucose from the blood
compared with the LF_PO (Figures 4a and b), although this
did not reach statistical significance for HF_OO (þ45.6% in
HF_PO versus LF_PO, Po0.005; þ38.5% in HF_CB versus
LF_PO, Po0.022; þ28.9% in HF_OO versus LF_PO, P¼0.16;
and þ45.4% in HF_SO versus LF_PO, Po0.003). No
significant differences between different HF groups were
evident. We found a positive correlation between the
incremental area under the blood glucose curve and
myocellular DAG and TAG content (Pearson correlation
coefficient¼0.35, P¼0.10, Figure 5a; Pearson correlation
coefficient¼0.43, P¼0.039, Figure 5b, respectively).
Skeletal muscle insulin signaling
Skeletal muscle IRS ser
307 phosphorylation, a marker of lipid-
induced insulin resistance, was similar between all dietary
groups (LF_PO, 0.81±0.04; HF_PO, 1.25±0.19; HF_CB,
0.96±0.14; HF_OO, 0.82±0.09; and HF_SO, 0.89±0.09AU,
P40.05).
GLUT4 protein content in sarcolemma was not affected by
the composition of the HF diets (LF_PO, 0.94±0.14; HF_PO,
1.05±0.09; HF_CB, 0.98±0.14; HF_OO, 1.08±0.20; and
HF_SO, 1.09±0.11AU, P40.05).
Liver lipid content
As liver is also an important organ involved in glucose
tolerance, liver fat content was also measured. Liver TAG
content was increased in mice receiving HF_PO and HF_OO
compared with mice receiving LF_PO, HF_CB and HF_SO
after 8 weeks of HF feeding (Po0.05, Figure 6).
Muscle oxidative capacity
We also examined whether the composition of the HF diets
lead to alterations in muscle oxidative capacity. Citrate
synthase activity in whole-muscle homogenate was similar
between the LF and the different HF groups (LF_PO,
21.88±1.59; HF_PO, 21.33±1.12; HF_CB, 19.10±0.89;
HF_OO, 22.93±2.23; and HF_SO, 21.49±0.94Ug
 1 protein,
P40.05). No differences in b-hydroxyacyl-CoA dehydrogenase
activity were detected between the different dietary groups,
indicating similar b-oxidative capacity (LF_PO, 34.70±4.79;
HF_PO, 37.95±3.10; HF_CB, 37.17±4.50; HF_OO,
36.98±6.75; and HF_SO, 35.64±6.47Ug
 1 protein, P40.05).
Eight weeks of HF feeding did not decrease PGC1a protein
levels, a strong marker of mitochondrial biogenesis
(Figure 7a). Moreover, mitochondrial density was not
statistically different between diets as determined by western
blotting of the structural complexes of the respiratory chain
Figure 4 Effect of dietary FA composition on whole-body glucose tolerance.
Glucose clearance after oral glucose bolus (2.5gkg
 1; a) and area under the
curve (AUC) of the glucose tolerance test (b). Data are expressed as
mean±s.e.m. (n¼6). *Po0.05 LF_PO versus HF_PO, HF_CB and HF_SO.
#Po0.05 LF_PO versus HF_PO and HF_SO.
Figure 5 Relation between glucose intolerance and total muscular DAG (a) and TAG (b) content. Correlations (r¼0.35 and P¼0.10, r¼0.43 and P¼0.039 for
DAG and TAG, respectively) are linear.
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protein levels of ATGL, the main lipase in the muscle
responsible for the breakdown of TAG to DAG was
unaffected by the composition of the different diets (LF_PO,
0.88±0.17; HF_PO, 0.94±0.10; HF_CB, 1.02±0.08; HF_OO,
1.12±0.12; and HF_SO, 1.08±0.12AU, P40.05).
Discussion
From literature, it is known that in conditions of a
continuous HF intake (that is, obesity), the degree of
saturation of the FAs in the diet might have a crucial role
in the development of obesity-related metabolic complica-
tions, as it might influence the storage form of FAs inside the
muscle. Therefore, the present study examined whether diets
varying in FA composition could differentially affect the rate
of body weight gain and the accumulation of fat in skeletal
muscle. Here, we show that after 8 weeks of HF feeding, only
HF_CB prevented body weight gain. Furthermore, we show
that a high dietary fat intake in the form of SO prevented the
accumulation of fat in skeletal muscle. Interestingly, the FA
Figure 6 Effect of dietary FA composition on liver TAG content. Data are
expressed as mean±s.e.m. (n¼6). *Po0.05 LF_PO, HF_CB and HF_SO versus
HF_PO and HF_OO.
Figure 7 Effect of dietary FA composition on the expression of PGC1a (a) and the individual complexes I, II, III and V of the respiratory chain (b–e)i n
gastrocnemius muscle. Data are expressed as mean±s.e.m. (n¼6).
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reflection of the dietary FA composition.
Eight weeks of HF feeding gradually increased body weight
in all dietary groups. However, the change in body weight
over the 8 weeks of dietary intervention varies between the
different HF diets. This indicates that besides the high
amount of fat, the type of FAs in the diet also influences the
rate of weight gain in the development of obesity, as food
intake was similar for all the dietary groups. Whereas HF_PO,
which is rich in palmitic acid (43% C16:0) and oleic acid
(41% C18:1), induced the highest increase in body weight
during the dietary intervention period, HF_CB only led to a
small increase in body weight, which was not significantly
different from the LF_PO diet. The lower body weight gain
for the HF_CB group can be explained by the fact that it is a
vegetable fat that is rich in SFAs; palmitic acid (C16:0); and
stearic acid (C18:0), thereby influencing the digestibility of
the lipid. Animal studies have shown that 5–20% CB in the
diet results in lower digestibility (60–70%), resulting in a
higher fecal lipid elimination.
28,29 In accordance, mice
receiving the HF_CB diet also had a higher feces production.
However, because food intake was only recorded during 1
week of the intervention, and feces was not analyzed for fat
content, we cannot exclude the possibility that cumulative
small, nonsignificant differences in food intake or a
difference in fat partitioning may underlie the reduced body
weight gain in these animals. Moreover, measurements of
24h energy expenditure would have been helpful in
interpreting energy and fat balance, but were not performed
in the current study.
At the end of the dietary intervention, the storage of lipids
inside the muscle for diets containing a high amount of SFAs
(HF_CB), MUFAs (HF_OO) or a combination of both (HF_PO)
were significantly increased compared with the LF_PO diet.
Interestingly, for HF_SO, myocellular TAG levels were
comparable to the LF_PO diet, indicating that a diet rich in
PUFAs does not result in skeletal muscle lipid accumulation.
For myocellular DAG accumulation, a similar pattern was
observed, whereas the HF diets compromising mostly SFAs
(HF_CB), MUFAs (HF_OO), or a combination of both types of
FAs (HF_PO) significantly elevated myocellular DAG con-
tent, HF_SO, containing primarily PUFAs, did not increase
DAG levels compared with the LF-fed animals.
These results indicate that diets rich in PUFAs may have
beneficial effects on myocellular fat accumulation and are in
line with reports showing a preferential oxidation of PUFAs,
whereas SFAs appear to be predominantly stored in muscle
rather than oxidized for energy.
15,30 The finding that the
HF_CB diet, which has by far the highest content of SFA and
leads to a reduced fat absorbance and body weight increase,
still increased DAG and TAG markedly, also suggests that
SFAs that are taken up are redirected toward storage as TAGs
and DAGs in skeletal muscle.
As it is well known that fat accumulation in muscle,
especially also in the form of DAG, may lead to muscle
insulin resistance, our data may also explain why dietary
MUFAs, and especially the PUFA linoleic acid (C18:2), have
been linked to improved insulin sensitivity.
31–33 In literature,
the beneficial effect of PUFAs on insulin sensitivity is
generally accounted for by a direct effect on insulin action
rather than lowering glucose values.
31 Unfortunately, we
could not determine insulin sensitivity in our study, but we
did find that whole-body glucose tolerance was positively
correlated with myocellular DAG and TAG levels. We also
measured makers of insulin sensitivity, such as IRS ser
307
phosphorylationFan indicator of lipid-induced insulin
resistance
34Fand GLUT4 protein content of the sarcolemma
but no changes were induced by the different dietary
treatments. As muscle lipid content is not the only
determinant of glucose tolerance, we also determined liver
TAG content. Again, HF_SO did not increase liver TAG after 8
weeks of HF feeding. Furthermore, HF_CB also did not
increase liver TAG. Further studies are necessary to examine
whether changes in myocellular and hepatic lipid accumula-
tion, induced by different types of dietary fat, will have
functional consequences, which, however, was out of the
scope of the present study.
We here also show that the dietary FA composition of the
individual HF diets is reflected in the FA pattern of both
myocellular TAG and DAG. Thus, the FA most represented in
the individual HF diets also accounted for the highest
percentage within both myocellular DAG and TAG content.
These data are consistent with findings in adipose tissue for
which it has also been shown that the FA composition of the
TAG fraction reflects the dietary patterns over a considerable
time.
20,21 It therefore seems that the dietary FA composition
affects skeletal muscle FA composition of both DAG and TAG
over a relatively short time. At this moment, too little
information is available on the impact of changes in muscle
FA composition on muscle function, although suggestions
have been made that diet-induced modifications in mem-
brane lipid composition are associated with changes in
energy metabolism and may impact substantially on diseases
such as the metabolic syndrome by influencing a range of
glucose- and lipid-handling pathways.
35 Clearly, more
information is needed on the impact of muscle FA composi-
tion on muscle metabolism, but our data are encouraging in
that respect. On another note, analysis of muscle FA
composition could help to test the adherence to diets in
short-term nutritional intervention studies, although this
would only be applicable in studies including invasive
measurements.
An explanation for the differences in muscle fat accumula-
tion between diets could be changes in fat oxidative and
mitochondrial capacity. Indeed, in recent years, several
studies have shown that a high intake of dietary fat affects
mitochondrial oxidative capacity in skeletal muscle.
36–41
Although the functional analysis of mitochondrial function
was out of scope of the present study, we did measure
markers of mitochondrial metabolism. Measurement
of citrate synthase activity revealed no such differences.
b-Hydroxyacyl-CoA dehydrogenase activity, reflecting
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varying FA composition.
Mitochondrial function was also assessed by measurement
of the OXPHOS complexes and PGC1a. However, we did not
observe a negative effect of HF feeding on these markers of
mitochondrial metabolism. Although we did not directly
measure the functional consequences of the different HF
diets, our results are in accordance with some recent studies
that also failed to show a negative effect of HF feeding on
mitochondrial function. Thus, we showed that an 8-week HF
dietary intervention in male Wistar rats did not affect the
intrinsic functioning of rat skeletal muscle mitochondria as
assessed by respirometry.
42 Also, Bonnard et al.
43 did not
detect mitochondrial dysfunction after a 4-week HF diet
intervention in C57BL/6J mice, whereas in an extended
dietary intervention of 16 weeks, altered mitochondrial
biogenesis, structure and function in muscle tissue were
observed. According to Bonnard et al.,
43 mitochondrial
alterations do not precede the onset of insulin resistance.
Possibly, this also holds true for our data, but our data do not
allow elaboration on insulin resistance.
As mitochondrial oxidative capacity could not explain
differences in muscle fat accumulation, we also examined
whether the different diets exert beneficial effects on muscle
fat balance by stimulating lipolysis. However, the measure-
ment of ATGL, the main lipase responsible for the break-
down of TAG into DAG, was unaffected by diet composition.
In summary, we show that after 8 weeks of HF feeding, the FA
profile of both TAG and DAG lipid intermediates in the muscle
mimicked the FA profile of the individual HF diets, indicating
that after a relatively short period the dietary fat intake relates
to the FA composition of the lipid metabolites in the muscle.
Furthermore, we show that a HF diet, rich in SO, is able to
prevent accumulation of fat in skeletal muscle. Finally, we
could not find evidence for a negative effect of HF diets on
markers of mitochondrial metabolism.
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